These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12920387)

  • 1. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study.
    Alvarez XA; Sampedro C; Pérez P; Laredo M; Couceiro V; Hernández A; Figueroa J; Varela M; Arias D; Corzo L; Zas R; Lombardi V; Fernández-Novoa L; Pichel V; Cacabelos R; Windisch M; Aleixandre M; Moessler H
    Int Clin Psychopharmacol; 2003 Sep; 18(5):271-8. PubMed ID: 12920387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects.
    Alvarez XA; Lombardi VR; Corzo L; Pérez P; Pichel V; Laredo M; Hernández A; Freixeiro F; Sampedro C; Lorenzo R; Alcaraz M; Windisch M; Cacabelos R
    J Neural Transm Suppl; 2000; 59():315-28. PubMed ID: 10961443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury.
    Zhang Y; Chopp M; Meng Y; Zhang ZG; Doppler E; Winter S; Schallert T; Mahmood A; Xiong Y
    J Neurosurg; 2015 Apr; 122(4):843-55. PubMed ID: 25614944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injury.
    Muresanu DF; Ciurea AV; Gorgan RM; Gheorghita E; Florian SI; Stan H; Blaga A; Ianovici N; Iencean SM; Turliuc D; Davidescu HB; Mihalache C; Brehar FM; Mihaescu AS; Mardare DC; Anghelescu A; Chiparus C; Lapadat M; Pruna V; Mohan D; Costea C; Costea D; Palade C; Bucur N; Figueroa J; Alvarez A
    CNS Neurol Disord Drug Targets; 2015; 14(5):587-99. PubMed ID: 25924999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration.
    Muresanu DF; Alvarez XA; Moessler H; Buia M; Stan A; Pintea D; Moldovan F; Popescu BO
    J Neurol Sci; 2008 Apr; 267(1-2):112-9. PubMed ID: 18048059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of Cerebrolysin on EEG and short-term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia.
    Funke M; Fiehler J; Mewes I; Eiselt M; Rother I; Windisch M
    J Neural Transm Suppl; 1998; 53():385-98. PubMed ID: 9700674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury.
    Alvarez XA; Sampedro C; Figueroa J; Tellado I; González A; García-Fantini M; Cacabelos R; Muresanu D; Moessler H
    J Neural Transm (Vienna); 2008 May; 115(5):683-92. PubMed ID: 18273537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat.
    Sharma HS; Zimmermann-Meinzingen S; Johanson CE
    Ann N Y Acad Sci; 2010 Jun; 1199():125-37. PubMed ID: 20633118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease.
    Wei ZH; He QB; Wang H; Su BH; Chen HZ
    J Neural Transm (Vienna); 2007; 114(5):629-34. PubMed ID: 17318304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cerebrolysin on functional recovery in patients with severe disability after traumatic brain injury: A historical cohort study.
    Khalili H; Niakan A; Ghaffarpasand F
    Clin Neurol Neurosurg; 2017 Jan; 152():34-38. PubMed ID: 27871029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
    Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H
    Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study.
    Muresanu DF; Alvarez XA; Moessler H; Novak PH; Stan A; Buzoianu A; Bajenaru O; Popescu BO
    J Neurol Sci; 2010 Dec; 299(1-2):179-83. PubMed ID: 20923712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrolysin in the treatment of brain injuries of moderate severity].
    Talypov AE; Myachin MY; Kuksova NS; Kordonsky AY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):98-106. PubMed ID: 25591645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and methods.
    Poon W; Vos P; Muresanu D; Vester J; von Wild K; Hömberg V; Wang E; Lee TM; Matula C
    J Neurotrauma; 2015 Apr; 32(8):571-80. PubMed ID: 25222349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of Cerebrolysin in patients with moderate to severe traumatic brain injury: Cognitive and functional outcomes.
    Soto C; Salinas P; Muñoz D; Olivares S; González J; Sáez V; Romero V
    J Med Life; 2023 Jul; 16(7):1017-1021. PubMed ID: 37900065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].
    Iznak EV; Iznak AF; Pankratova EA; Zavadenko NN; Guzilova LS; Guzilova IuI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):27-32. PubMed ID: 21322822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological effects and brain protection by hypothermia and cerebrolysin after moderate forebrain ischemia in rats.
    Schwab M; Bauer R; Zwiener U
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):105-16. PubMed ID: 9085084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.